1.2.1 promote an exchange of best practices between member states on public-health-orientated responses to problem drug use;
1.2.2 promote a dialogue on problem drug use in the context of public health policy making;
1.2.3 support the collection of comparable data and the development of indicators on effective responses to problem drug use;
1.2.4 formulate and adopt a new framework convention on drug policy which consolidates existing scientific and medical knowledge and which may subsequently form the basis of member states’ national drug policies.